As an investor, you can get an idea of where the stock is trending by the forecast and beta. Reta) is scheduled to announce q3 earnings results on monday, november 8th, before market open.
According to present data reata pharmaceuticals's 2r3 shares and potentially its market environment have been in bearish cycle last 12 months (if exists).
Reata pharmaceuticals stock forecast. Eric volkman has no position in any of the stocks mentioned. Machine learning based stock forecast (n+30) for reta reata pharmaceuticals as below: Shares of reata pharmaceuticals stock opened at $105.41 on thursday.
Our reata pharmaceuticals inc consensus estimates page is based on consensus analyst forecast, covering public companies earnings per share and revenue. The motley fool owns shares of and recommends reata pharmaceuticals, inc. Anyone who purchased reata pharmaceuticals, inc.
Stock was originally listed at a price of $13.07 in may 26, 2016. 1 day) and results in a price target of $95.87. This suggests a possible upside of 159.8% from the stock's current price.
On average, they expect reata pharmaceuticals' share price to reach $211.67 in the next twelve months. This compares to loss of $1.94 per share a year ago. Frankfurt stock market & finance report, prediction for the future:
73 rows analyst price target is. Cantor fitzgerald also issued estimates for reata pharmaceuticals' fy2022 earnings at ($8.83) eps. Pharmaceuticals industry in the us expected to see average net income growth of 14% next year.
You'll find the reata pharmaceuticals share forecasts, stock quote and buy / sell signals below. Reata pharmaceuticals inc has risen higher in 2 of those 5 years over the subsequent 52 week period, corresponding to a historical accuracy of 40 % On average, wall street analysts predict that.
See the 10 stocks *stock advisor returns as of november 10, 2021. The number of outstanding shares for reata pharmaceuticals inc is 31464000. Beta is calculated using regression analysis.
Now that you know more about reata pharmaceuticals inc stands, let’s learn more about the future of the company. The average reata pharmaceuticals stock price prediction forecasts a potential downside of n/a from the current reta share price of $84.85. If you had invested in reata pharmaceuticals stock at $13.07, your return over the last 5 years would have been 549.2%, for an annualized return of 45.37% (not including any dividends or dividend reinvestments).
Consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Stock forecast (buy or sell) machine learning utilizes multiple learning algorithms to obtain better predictive powers. Consensus price target down from us$237 to us$226.
The forecast for the further price development, based on current price information, is 5.77% (time horizon: Reata pharmaceuticals inc (reta:nmq) forecasts: In our research, we utilize machine learning to combine the results from the neural network and support vector machines.
The consensus outlook for revenues in 2021 has improved. Reata pharmaceuticals's share price could stay at $211.67 by may 24, 2022. The latest earnings per stock, revenues and financial reports for reata pharmaceuticals inc (reta).
3 wall street analysts have issued 12 month price objectives for reata pharmaceuticals' shares. As of 2021 november 16, tuesday current price of reta stock is 102.450$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). Stock between november 14, 2016 and december 6, 2021 and has lost money may be eligible, whether or not they have sold their investment.
Over the next 52 weeks, reata pharmaceuticals inc has on average historically risen by 57.4 % based on the past 5 years of stock performance. You'll be provided with reata pharma. Duncan now anticipates that the company will post earnings of ($8.13) per share for the year, down from their prior forecast of ($8.11).
Reata pharmaceuticals inc stock forecast. Wall street stock market & finance report, prediction for the future: 2021 revenue forecast increased from us$5.21m to us$6.63m.
About the reata pharmaceuticals, inc. Their forecasts range from $155.00 to $244.00. Find the latest reata pharmaceuticals, inc.
The company's stock plunged nearly 40% on december 6, 2021 after the briefing documents were released. (reta) came out with a quarterly loss of $1.97 per share versus the zacks consensus estimate of a loss of $2.32. (reta) stock quote, history, news and other vital information to help you with your stock trading and investing.
